{
    "id": "a8290e603a",
    "abstract": [],
    "body_text": [
        {
            "text": "lthough the brain does not use free fatty acids (FFAs) as an energy source, recent evidence suggests that FFAs and, specifically, their intermediates could have a key role in the central control of energy balance regulation and feeding (1)(2)(3)(4)(5). ",
            "section": "A",
            "ref_spans": [
                {
                    "start": 236,
                    "end": 239,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "(1)"
                },
                {
                    "start": 239,
                    "end": 242,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "(2)"
                },
                {
                    "start": 242,
                    "end": 245,
                    "type": "bibr",
                    "ref_id": "b2",
                    "text": "(3)"
                },
                {
                    "start": 245,
                    "end": 248,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "(4)"
                },
                {
                    "start": 248,
                    "end": 251,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "(5)"
                }
            ]
        },
        {
            "text": "Both brain FFA uptake and metabolism are currently insufficiently defined, whereas the importance of FFAs in the pathogenesis of metabolic syndrome (MS) is demon-strated widely in other organs (6,7). ",
            "section": "A",
            "ref_spans": [
                {
                    "start": 193,
                    "end": 196,
                    "type": "bibr",
                    "ref_id": "b5",
                    "text": "(6,"
                },
                {
                    "start": 196,
                    "end": 198,
                    "type": "bibr",
                    "ref_id": "b6",
                    "text": "7)"
                }
            ]
        },
        {
            "text": "Animal studies have demonstrated that hypothalamic sensing of circulating fatty acids in general is believed to be important in controlling nutrient intake and, thus, energy balance. ",
            "section": "A"
        },
        {
            "text": "For example, Pocai et al. (5) showed that manipulation of central hypothalamic FFA metabolism normalizes energy and glucose homeostasis in overfed rats. ",
            "section": "A",
            "ref_spans": [
                {
                    "start": 26,
                    "end": 29,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "(5)"
                }
            ]
        },
        {
            "text": "These regulatory processes are difficult to address in humans in vivo, and most data in this regard have been demonstrated in small animals (1,4,5,8). ",
            "section": "A",
            "ref_spans": [
                {
                    "start": 140,
                    "end": 143,
                    "type": "bibr",
                    "ref_id": "b0",
                    "text": "(1,"
                },
                {
                    "start": 143,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "4,"
                },
                {
                    "start": 145,
                    "end": 147,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "5,"
                },
                {
                    "start": 147,
                    "end": 149,
                    "type": "bibr",
                    "ref_id": "b7",
                    "text": "8)"
                }
            ]
        },
        {
            "text": "More work is needed to clarify the mechanisms behind the complex hypothalamic regulatory circuitry that regulates energy expenditure and feeding behavior.",
            "section": "A"
        },
        {
            "text": "Positron emission tomography (PET) and other methods have been used to evaluate the fate of long-chain saturated fatty acid carbon-labeled-palmitate (9 -12). ",
            "section": "A",
            "ref_spans": [
                {
                    "start": 149,
                    "end": 156,
                    "type": "bibr",
                    "text": "(9 -12)"
                }
            ]
        },
        {
            "text": "PET provides a method for noninvasive, quantitative, and regional measurement of FFA uptake, thus making it ideal for studying metabolism in different tissues (13). ",
            "section": "A",
            "ref_spans": [
                {
                    "start": 159,
                    "end": 163,
                    "type": "bibr",
                    "ref_id": "b12",
                    "text": "(13)"
                }
            ]
        },
        {
            "text": "The status of brain FFA metabolism in MS is currently unknown. ",
            "section": "A"
        },
        {
            "text": "Therefore, our aim was to use PET to examine possible difference in the brain FFA-uptake rates between MS patients and healthy individuals.",
            "section": "A"
        },
        {
            "text": "Subjects. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Twenty-three subjects with MS (age 43 \u03ee 7 years, BMI 33.6 \u03ee 4.0 kg/m 2 , 8 men and 15 women) and 7 age-matched healthy men (age 42 \u03ee 11 years, BMI 26.8 \u03ee 2.5 kg/m 2 ) ( Table 1) were recruited, mostly from an occupational healthy service clinic. ",
            "section": "RESEARCH DESIGN AND METHODS",
            "ref_spans": [
                {
                    "start": 169,
                    "end": 177,
                    "type": "table",
                    "ref_id": "tab_1",
                    "text": "Table 1)"
                }
            ]
        },
        {
            "text": "Healthy patients were nonobese and had normal oral glucose tolerance test results, whereas the 23 MS patients had MS according to the current International Diabetes Federation criteria (14) ( Table  2). ",
            "section": "RESEARCH DESIGN AND METHODS",
            "ref_spans": [
                {
                    "start": 192,
                    "end": 200,
                    "type": "table",
                    "ref_id": "tab_2",
                    "text": "Table  2"
                }
            ]
        },
        {
            "text": "According to the criteria, a person defined as having MS must have central obesity, defined as increased waist circumference plus at least two other additional criteria (raised triglycerides/blood pressure/fasting glucose or reduced HDL). ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Subjects were told to use no alcohol during the study period. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Smoking was an exclusion criterion. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Only 1 of 23 subjects with MS used medication (ACE inhibitor for blood pressure). ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Written informed consents were obtained after explaining the purpose and potential risks of the study to the subjects. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "The study protocol was approved by the Ethics Committee of the Hospital District of Southwest Finland and conducted according to the principles of the declaration of Helsinki. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Study design. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "The study was designed to assess ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "1) the differences between MS patients and healthy individuals at baseline, and ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "2) the effect of a very low caloric diet (VLCD) in MS patients. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Two PET studies were performed, first with [ 11 C]-palmitate, and thereafter with [ 18 F]fluoro-6-thia-heptadecanoic acid ([ 18 F]-FTHA), either during the same day or on separate days within 1 week. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "A subgroup of patients with MS (n \u03ed 16) were prescribed a VLCD. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "All daily meals were replaced by diet products for 6 weeks (Nutrifast, Leiras, Finland, 2.3 MJ (megajoule), 4.5 g fat, 59 g protein, and 72 g carbohydrate per day). ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "After the diet there was a 1-week recovery period with an isocaloric diet to avoid catabolic state. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "The isocaloric diet was based on estimations of energy expenditure and was introduced by a physician. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "The assessments using PET were repeated. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Magnetic resonance images were obtained for anatomical reference. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "Production and nature of radiotracers. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "The production of [ 11 C]-palmitate (half-life 20.4 min) (15) and the production of [ 18 F]-FTHA (half-life 109 min): (16) are described elsewhere. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "The radiochemical purity of the final product was \u03fe98% for both tracers.",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "]fluoro-6-thia-heptadecanoic acid) is a long-chain FA analog that has a sulfur-substitution in the sixth carbon and a radioactive fluorine-18 label. ",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "[ 18 F]-FTHA which is taken up by tissues and subsequently either enters mitochondria or is incorporated into complex lipids (16). ",
            "section": "RESEARCH DESIGN AND METHODS",
            "ref_spans": [
                {
                    "start": 125,
                    "end": 129,
                    "type": "bibr",
                    "ref_id": "b15",
                    "text": "(16)"
                }
            ]
        },
        {
            "text": "In mitochondria, [ 18 F]FTHA undergoes initial steps of \u2424-oxidation and is thereafter trapped as further \u2424-oxidation is blocked by its sulfur heteroatom (17). ",
            "section": "RESEARCH DESIGN AND METHODS",
            "ref_spans": [
                {
                    "start": 153,
                    "end": 157,
                    "type": "bibr",
                    "ref_id": "b16",
                    "text": "(17)"
                }
            ]
        },
        {
            "text": "Because of these properties, [ 18 F]-FTHA provides optimal target-to-background signal in PET images.",
            "section": "RESEARCH DESIGN AND METHODS"
        },
        {
            "text": "To validate the biodistribution of both [ 18 F]-FTHA and [ 13 C]palmitate in brain, we used data from in vivo pig [ 18 F]-FTHA biodistribution study (18), and completed the study by analyzing the biodistribution of stable [ 13 C]-palmitate from frozen brain samples obtained from the same animals. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain.",
            "ref_spans": [
                {
                    "start": 149,
                    "end": 153,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "(18)"
                }
            ]
        },
        {
            "text": "The study protocol and analysis of [ 18 F]-FTHA has been described in detail elsewhere (18), and the palmitate information is provided in an online appendix in an online appendix available at http://diabetes.diabetesjournals. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain.",
            "ref_spans": [
                {
                    "start": 87,
                    "end": 91,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "(18)"
                }
            ]
        },
        {
            "text": "org/cgi/content/full/db09-0138/DC1. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "The results are provided in Table 3. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain.",
            "ref_spans": [
                {
                    "start": 28,
                    "end": 35,
                    "type": "table",
                    "ref_id": "tab_3",
                    "text": "Table 3"
                }
            ]
        },
        {
            "text": "Roughly 62% from [ 13 C]-palmitate and 69% from [ 18 F]-FTHA was found in brain lipids. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "Most of the [ 13 C]-palmitate in brain lipids was found in phospholipids, and only trace amounts were found in triglycerides and fatty acids. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "[ 18 F]-FTHA was found mostly in triglycerides. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "PET studies. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "Patients were scanned in the fasting state, and they refrained from drinks containing caffeine, smoking, and all medications for 12 h before the PET scan. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "Studies were performed in a supine position. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "Two catheters were inserted in the antecubital veins of different arms: one for saline infusion and tracer injection, and another for blood sampling. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "[  Image acquisition, processing, and corrections. Most studies were performed using GE Discovery PET-CT STE (GE, Medical Systems, Milwaukee, WI), but because of the short half-life of [ 11 C]-palmitate, Siemens ECAT HR\u03e9 (Knoxville, TN) and GE Advance (GE Medical Systems, Milwaukee, WI) were in use when this tracer was divided. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain.",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 1,
                    "type": "bibr",
                    "text": "["
                }
            ]
        },
        {
            "text": "The second study was scanned with same camera-protocol as the first study. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "Data were corrected for dead-time, decay, and photon attenuation. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "PET images were reconstructed in GE Advance using a 128 \u03eb 128 matrix with a 30-cm field of view (FOV) in three-dimensional (3D) mode and Filtered Back Projection (FBP) reconstruction, in Siemens HR\u03e9 using 128 \u03eb 128 matrix with zoom two (28. ",
            "section": "In vivo validation of biodistribution of [ 18 F]-FTHA and [ 13 C]-palmitate in pig brain."
        },
        {
            "text": "Compared with the healthy control subjects, patients with MS had higher fasting plasma glucose concentrations (Table 1), but otherwise no significant differences in oral glucose tolerance test (OGTT) results between healthy control patients and MS patients were found. ",
            "section": "Metabolic characteristics during the study.",
            "ref_spans": [
                {
                    "start": 110,
                    "end": 119,
                    "type": "table",
                    "ref_id": "tab_1",
                    "text": "(Table 1)"
                }
            ]
        },
        {
            "text": "After VLCD, subjects with MS lost weight \u03f311.1 kg (range 7.2-15.4 kg, P \u03fd 0.0001), whereas total cholesterol (P \u03fd 0.0001), LDL (P \u03fd    (Fig. 2), radioactivity was highest in the thalamus (the two largest gray matter nuclei in the center of the transaxial image), followed by high uptake in the basal ganglia and throughout the cerebral cortex. ",
            "section": "Metabolic characteristics during the study.",
            "ref_spans": [
                {
                    "start": 135,
                    "end": 143,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "(Fig. 2)"
                }
            ]
        },
        {
            "text": "Brain FFA uptake in healthy subjects and patients with MS. When brain FFA uptake was measured using [ 18 F]-FTHA and the values of plasma FFA concentration during PET, the brain FFA uptake was significantly higher in patients with MS compared with healthy subjects (Fig.  2). ",
            "section": "Metabolic characteristics during the study.",
            "ref_spans": [
                {
                    "start": 265,
                    "end": 274,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "(Fig.  2)"
                }
            ]
        },
        {
            "text": "The mean percentage increase was \u03e9130% in the white matter and \u03e947% in the gray matter, and respective standardized effect sizes were 1.83 and 0.88. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The main effect of the group was significant in the repeated measures ANOVA (rmANOVA) (F \u03ed 7.38, P \u03ed 0.012), whereas no effect from the scanner was observed. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "In addition, the group \u03eb region interaction was significant (F \u03ed 5.35, P \u03ed 0.016), indicating that the group difference in [ 18 F]-FTHA uptake was not uniform across brain regions. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "Regional ANOVAs indicated significant group differences in all regions: white matter (P \u03ed 0.001), anterior cingulate (P \u03ed 0.038), parietal (P \u03ed 0.015), temporal (P \u03ed 0.015) and prefrontal cortex (P \u03ed 0.020), amygdala-hippocampal complex (P \u03ed 0.014), striatum (P \u03ed 0.019), and hypothalamus (P \u03ed 0.007). ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The mean percentage increment in the hypothalamic area was \u03e952% among the subjects with MS compared with healthy subjects. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "No scanner effects were seen in any region. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "A marked elevation was also found in the brain uptake of [ 11 C]-palmitate in patients with MS when compared with healthy controls (Fig. 2). ",
            "section": "Metabolic characteristics during the study.",
            "ref_spans": [
                {
                    "start": 131,
                    "end": 139,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "(Fig. 2)"
                }
            ]
        },
        {
            "text": "The average increase was \u03e983.8% in the white matter and \u03e987.7% in the gray matter. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The standardized effect sizes were of large magnitude, 1.24 in both the white and gray matter.",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The rmANOVA also demonstrated a significant main effect of group (P \u03ed 0.017). ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "Because different PET-scanners were used in this study, we wanted to test whether the use of different PET-scanners would have an impact on the findings. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The rmANOVA demonstrated no effects of the scanner (P \u03ed 0.959). ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The group \u03eb region interaction was also significant (P \u03ed 0.016), suggesting that elevation  (Fig. 3). ",
            "section": "Metabolic characteristics during the study.",
            "ref_spans": [
                {
                    "start": 92,
                    "end": 100,
                    "type": "figure",
                    "text": "(Fig. 3)"
                }
            ]
        },
        {
            "text": "The mean percentage decrease was \u03ea17.5% in the white matter and \u03ea17.6% in the gray matter. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "In the rmANOVA, the main effect of repetition was statistically significant (P \u03ed 0.010), whereas the repetition \u03eb region interaction was not (P \u03ed 0.099). ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The latter suggests that the decrease in tracer uptake was  uniform across brain regions. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "Therefore, to avoid type 1 errors, regional changes were not formally assessed. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "This result was confirmed using a voxel-based mapping analysis (Fig. 3). ",
            "section": "Metabolic characteristics during the study.",
            "ref_spans": [
                {
                    "start": 63,
                    "end": 71,
                    "type": "figure",
                    "text": "(Fig. 3)"
                }
            ]
        },
        {
            "text": "The change in [ 11 C]-palmitate uptake was highly variable between individuals, with the average across regions ranging from \u03ea37% to \u03e9210% and the average across individuals being \u03e932% (SD 74%). ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "The rmANOVA did not show any significant change in [ 11 C]palmitate uptake after VLCD (Fig. 3, main effect of repetition: P \u03ed 0.712, repetition \u03eb region interaction: P \u03ed 0.676). ",
            "section": "Metabolic characteristics during the study.",
            "ref_spans": [
                {
                    "start": 86,
                    "end": 93,
                    "type": "figure",
                    "text": "(Fig. 3"
                }
            ]
        },
        {
            "text": "The change in [ 18 F]-FTHA uptake versus change in [ 11 C]-palmitate correlated positively in all brain areas, and all of the correlations were statistically significant. ",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "For the hypothalamus, the correlation r value was 0.56 (P \u03fd 0.05).",
            "section": "Metabolic characteristics during the study."
        },
        {
            "text": "Brain fatty acid uptake measured with [ 18 F]-FTHA-PET was positively associated with age (P \u03ed 0.007, r \u03ed 0.52), fasting serum insulin (P \u03fd 0.05, r \u03ed 0.40) and homeostasis model assessment (HOMA) index (P \u03ed 0.04, r \u03ed 0.41) (Fig.  4). ",
            "section": "Fatty acid uptake and metabolic characteristics.",
            "ref_spans": [
                {
                    "start": 223,
                    "end": 232,
                    "type": "figure",
                    "text": "(Fig.  4)"
                }
            ]
        },
        {
            "text": "The correlation between [ 18 F]-FTHA and age persisted after the data were adjusted for BMI (P \u03fd 0.03, r \u03ed 0.46). ",
            "section": "Fatty acid uptake and metabolic characteristics."
        },
        {
            "text": "Both total and nonoxidized fraction of fatty acid uptake were positively associated with the BMI (total: P \u03ed 0.002, nonoxidized: P \u03ed 0.004).",
            "section": "Fatty acid uptake and metabolic characteristics."
        },
        {
            "text": "To our knowledge, this is the first study to investigate brain FFA uptake in obese patients with MS. The main finding of the study is that patients with MS have higher FFA uptake in the brain compared with healthy subjects. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Weight loss reduced FFA uptake more in healthy subjects, and this was more due to decreased FFA oxidation rather than decreased metabolic FFA utilization. ",
            "section": "DISCUSSION"
        },
        {
            "text": "We and others have previously used [ 18 F]-FTHA and PET to quantify regional FFA metabolism, especially in myocardium and skeletal muscle (18,20,21). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 138,
                    "end": 142,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "(18,"
                },
                {
                    "start": 142,
                    "end": 145,
                    "type": "bibr",
                    "ref_id": "b19",
                    "text": "20,"
                },
                {
                    "start": 145,
                    "end": 148,
                    "type": "bibr",
                    "ref_id": "b20",
                    "text": "21)"
                }
            ]
        },
        {
            "text": "Recently we showed that [ 18 F]-FTHA accumulates in the brain in significant amounts (18), thus making it a reliable tracer to quantify brain FFA uptake. ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 85,
                    "end": 89,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "(18)"
                }
            ]
        },
        {
            "text": "The brain tissue-input ratio for [ 18 F]-FTHA ratio was high, suggesting that [ 18 F]-FTHA crosses the blood-brain barrier and accumulates persistently and in measurable amounts. ",
            "section": "DISCUSSION"
        },
        {
            "text": "More than half of the tracer was going into the lipids, and less than half into the breakdown products (18). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 103,
                    "end": 107,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "(18)"
                }
            ]
        },
        {
            "text": "These breakdown products likely represent oxidation, so the study results suggest that [ 18 F]-FTHA reflects total uptake. ",
            "section": "DISCUSSION"
        },
        {
            "text": "[ 11 C]-palmitate has been shown to accumulate in monkey brain (9) and the extracted fraction is independent of cerebral flow (22). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 63,
                    "end": 66,
                    "type": "bibr",
                    "ref_id": "b8",
                    "text": "(9)"
                },
                {
                    "start": 126,
                    "end": 130,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "(22)"
                }
            ]
        },
        {
            "text": "Palmitate accumulation in the brain has also been verified in rats (11,(23)(24)(25), and the flux is proportional to published values for regional brain oxidative metabolism (23). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 67,
                    "end": 71,
                    "type": "bibr",
                    "ref_id": "b10",
                    "text": "(11,"
                },
                {
                    "start": 71,
                    "end": 75,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "(23)"
                },
                {
                    "start": 75,
                    "end": 79,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "(24)"
                },
                {
                    "start": 79,
                    "end": 83,
                    "type": "bibr",
                    "ref_id": "b24",
                    "text": "(25)"
                },
                {
                    "start": 174,
                    "end": 178,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "(23)"
                }
            ]
        },
        {
            "text": "Longchain saturated fatty acids such as [ 11 C]-palmitate enter, to a large extent (50 -60%), via \u2424-oxidation in mitochondria, creating radioactive, aqueous metabolites, particularly glutamate, glutamine, and aspartate, whereas the other half is incorporated into lipids (22,26,27). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 271,
                    "end": 275,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "(22,"
                },
                {
                    "start": 275,
                    "end": 278,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "26,"
                },
                {
                    "start": 278,
                    "end": 281,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "27)"
                }
            ]
        },
        {
            "text": "After the fast oxidation of [ 11 C]-palmitate, the remaining radioactivity thus enters the stable lipid pool of the brain representing nonoxidative residual. ",
            "section": "DISCUSSION"
        },
        {
            "text": "It has been suggested that 83% of brain radioactivity is in stable compartments within 2 min after a steady-state level of plasma palmitate is achieved (9). ",
            "section": "DISCUSSION"
        },
        {
            "text": "Plasma [ 11 C]-palmitate activity in our study was stable shortly after 5 min in each person. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Because the analysis was done using time frames of 10 -20 min, the palmitate results from brain can be considered to represent incorporation to stable compartments, and thus the so-called nonoxidative residual. ",
            "section": "DISCUSSION"
        },
        {
            "text": "We speculate that by combining the information F]-FTHA was not uniformly increased in all brain areas. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The total FFA uptake was significantly greater in the white matter among subjects with MS compared with healthy controls, and the increment appeared to be of larger magnitude than that in the gray matter. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The increase in white matter [ 18 F]-FTHA uptake could contribute to previous findings of brain white matter expansion among obese subjects (28). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 140,
                    "end": 144,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "(28)"
                }
            ]
        },
        {
            "text": "The differ- ence with [ 11 C]-palmitate between groups was more uniform and thus statistically significant in all analyzed areas. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The hypothalamic area, now associated with fatty acid sensing and regulation of energy balance and feeding (2,4), had also increased uptake of ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 107,
                    "end": 110,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "(2,"
                },
                {
                    "start": 110,
                    "end": 112,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "4)"
                }
            ]
        },
        {
            "text": "]-palmitate could be that oxidative metabolism might be more flexible in nature, whereas the synthesis of complex lipids may be more preserved due to its important structural role in the brain. ",
            "section": "DISCUSSION"
        },
        {
            "text": "In addition, these studies were conducted under fasting conditions, which are characterized by activation of FFA oxidative metabolism. ",
            "section": "DISCUSSION"
        },
        {
            "text": "This may also help explain why intervention-related differences in this process are more easily identified than those in storage. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The dieting period did not affect fasting plasma FFA levels, thus multiplying image data with individual FFA level does not contribute to the observed decrease in FFA uptake.",
            "section": "DISCUSSION"
        },
        {
            "text": "Our findings are consistent with recent studies implicating the role of hypothalamic fatty acid sensing and their role in the regulation of feeding, energy balance (2,4,5), and peripheral physiologic processes (29). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 164,
                    "end": 167,
                    "type": "bibr",
                    "ref_id": "b1",
                    "text": "(2,"
                },
                {
                    "start": 167,
                    "end": 169,
                    "type": "bibr",
                    "ref_id": "b3",
                    "text": "4,"
                },
                {
                    "start": 169,
                    "end": 171,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "5)"
                },
                {
                    "start": 210,
                    "end": 214,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "(29)"
                }
            ]
        },
        {
            "text": "The normalization of hypothalamic lipid sensing has been linked to normalization of energy and glucose homeostasis (5). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 115,
                    "end": 118,
                    "type": "bibr",
                    "ref_id": "b4",
                    "text": "(5)"
                }
            ]
        },
        {
            "text": "From our study results, it seems that the normal catabolic effect of central FFAs is disturbed in obesity, and this is at least partially reversible after weight loss. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Peripheral insulin resistance contributing to MS could also affect the brain. ",
            "section": "DISCUSSION"
        },
        {
            "text": "In healthy pigs, hyperinsulinemia induced \u03f320 -50% decrease in brain [ 18 F]-FTHA radioactivity compared with fasting state (18). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 124,
                    "end": 128,
                    "type": "bibr",
                    "ref_id": "b17",
                    "text": "(18)"
                }
            ]
        },
        {
            "text": "The hypothesized central insulin resistance could interfere with brain glucose utilization, thus resulting in compensatory increased FFA uptake and FFA oxidation. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Weight loss is known to improve insulin sensitivity and plasma lipid profile (30). ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 77,
                    "end": 81,
                    "type": "bibr",
                    "ref_id": "b29",
                    "text": "(30)"
                }
            ]
        },
        {
            "text": "The beneficial effect of weight loss was observed in our study among MS patients; in addition to beneficial peripheral effects, FFA uptake in the brain was uniformly decreased due to a decrease in FFA oxidation. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The correlations from our study corroborate this line of interference: FFA uptake was positively correlated with BMI, plasma insulin, and HOMA-index; among these, BMI had the strongest correlation. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Brain FFA uptake also increased with ageing, suggesting that ageing is related to degenerative changes in the metabolic processes, and reinforcing the theory that age is a risk factor for MS.",
            "section": "DISCUSSION"
        },
        {
            "text": "Given that the activation of hypothalamic nuclei can result in changes in sympathetic tone, and that hypothalamus is a key regulator in feeding and energy balance, it is interesting to hypothesize that central FFAs could contribute to increased sympathetic tone in obesity. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Previous studies support both positive and negative effects of central lipids in sympathetic tone. ",
            "section": "DISCUSSION"
        },
        {
            "text": "It has been reported that central lipid infusion resulting in increased brain lipids might modulate sympathoadrenal response (31), and that intracerebrovascular infusion of fatty acids might lower sympathetic activity. ",
            "section": "DISCUSSION",
            "ref_spans": [
                {
                    "start": 125,
                    "end": 129,
                    "type": "bibr",
                    "ref_id": "b30",
                    "text": "(31)"
                }
            ]
        },
        {
            "text": "Unfortunately, we did not have any direct measurements to address this question.",
            "section": "DISCUSSION"
        },
        {
            "text": "Limitations in this study were the small number of subjects in the healthy control group and the fact that all of the healthy subjects were males. ",
            "section": "DISCUSSION"
        },
        {
            "text": "If sex is used in the statistical model as a covariate, the group difference in [ 18 F]-FTHA uptake persists in the white matter (group \u03eb region: F \u03ed 6.72, P \u03ed 0.007; main effect of group in the white matter: F \u03ed 4.92, P \u03ed 0.037), but not in other brain regions, and no significant effects are seen with [ 18 F]palmitate. ",
            "section": "DISCUSSION"
        },
        {
            "text": "In addition, female patients with MS had higher uptake values for both radioligands than male patients with MS. Future studies including healthy females should establish whether a significant interaction exists between sex and disease status, such that female patients may be more severely affected than male patients, as current data suggest. ",
            "section": "DISCUSSION"
        },
        {
            "text": "However, we think that a simple confounding main effect of sex is unlikely to explain the current results, based on three facts. ",
            "section": "DISCUSSION"
        },
        {
            "text": "First, [ 18 F]-FTHA uptake is increased in MS in white matter even when sex is taken into account. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Second, significant correlations were seen between fatty acid uptake and clinical variables, such as BMI and fasting plasma glucose, suggesting that increased fatty acid uptake is more likely related to metabolic abnormalities than sex alone. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Third, the significant decrease in fatty acid uptake after weight loss argues against a main effect of sex because such main effect would not be reversible. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Nevertheless, we acknowledge the skewed sex distribution as a limitation to the interpretation of the results, and recommend that sex be taken into account in future studies. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The number of subjects having MS differs in cross-section versus VLCD intervention. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The first phase of the study was only cross-sectional. ",
            "section": "DISCUSSION"
        },
        {
            "text": "After having positive results from phase 1, we wanted to study in more detail the possibility that brain FFA uptake is related to weight. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The more comprehensive phase two (VLCD intervention) was introduced in the study protocol and the last 16 of 23 subjects took part in this phase. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Another limiting factor is that the brain kinetics of [ 18 F]-FTHA is not known so well as in other organs and was assumed to be taken up as natural palmitate. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Although the in vivo biodistribution of [ 18 F]-FTHA in the brain suggests that [ 18 F]-FTHA represents total uptake, it does not prove that it equals uptake of natural FFAs. ",
            "section": "DISCUSSION"
        },
        {
            "text": "In our study, the total oxidation of [ 11 C]palmitate was found to be less than 50%. ",
            "section": "DISCUSSION"
        },
        {
            "text": "In the animal studies, it has been found that approximately 60% of the [ 11 C]-palmitate enters to \u2424-oxidation (9). ",
            "section": "DISCUSSION"
        },
        {
            "text": "It is possible that the kinetic properties of [ 18 F]-FTHA differ slightly from our assumption, explaining the slight difference between our study and animal studies. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Nevertheless, this would not affect the differences found between the two groups. ",
            "section": "DISCUSSION"
        },
        {
            "text": "The dosages of injected tracers did not explain the findings, even when weight was taken into account. ",
            "section": "DISCUSSION"
        },
        {
            "text": "In addition, the isocaloric diet was not controlled, but the subjects were free to eat what they wanted. ",
            "section": "DISCUSSION"
        },
        {
            "text": "So the quality and quantity of the foods probably differ between subjects.",
            "section": "DISCUSSION"
        },
        {
            "text": "To conclude, we have found that patients fulfilling the International Diabetes Federation criteria of metabolic syndrome have increased brain FFA uptake when compared with healthy subjects. ",
            "section": "DISCUSSION"
        },
        {
            "text": "Weight loss is able to partly reverse this abnormality. ",
            "section": "DISCUSSION"
        },
        {
            "text": "These novel findings highlight the possible role of brain FFAs in regulation of body weight. ",
            "section": "DISCUSSION"
        },
        {
            "text": "It seems that the normal catabolic effect of central FFAs is disturbed in MS and this is partially reversed after weight loss.",
            "section": "DISCUSSION"
        },
        {
            "text": "The study was conducted in the Finnish Centre of Excellence in Molecular Imaging in Cardiovascular and Metabolic Research, supported by the Academy of Finland, University of Turku, Turku University Hospital, and \u00c5bo Academy University. ",
            "section": "ACKNOWLEDGMENTS"
        },
        {
            "text": "Support was also received by grants from the HEPADIP EU FP6 program, the Novo Nordisk Foundation, and the Hertta and Veikko Valtonen Foundation.",
            "section": "ACKNOWLEDGMENTS"
        },
        {
            "text": "No other potential conflicts of interest relevant to this article were reported.",
            "section": "ACKNOWLEDGMENTS"
        },
        {
            "text": "A.K. wrote the manuscript, researched data, contributed to discussion, and reviewed/edited the manuscript. ",
            "section": "ACKNOWLEDGMENTS"
        },
        {
            "text": "P.I. ",
            "section": "ACKNOWLEDGMENTS"
        }
    ]
}